The primary objective of the current study is to assess cancer patient perceived barriers to adherence to oral cancer medications. The results of this survey will aid clinicians in identifying targeted priorities in future programs aimed at improving adherence in patients taking oral cancer medications.
Thank you for your interest, but this study is recruiting by invitation only.
North Carolina (Orange)
Benyam Muluneh
UNC Eshelman School of Pharmacy-Division of Pharmacotherapy and Experimental Therapeutics
Behavioral or Social
Observational
Behavior
Cancer (Brain and Other Nervous System, Breast, Colorectal, Head and Neck, Kidney, Liver, Lung, Melanoma, Pediatric Cancers, Prostate, Thyroid and Other Gland/Endocrine, Leukemia, Lymphoma, Multiple Myeloma, Ovarian)
22-1317
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
